Cryo-Cell International vs Celularity
CCEL and CELU side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CCEL and CELU compare
Cryo-Cell International is the larger company, worth 1.9 times as much as Celularity ($39.1M against $20.4M).
Cryo-Cell International grew revenue faster over the last twelve months (−2.0% versus −58.1% for Celularity).
Cryo-Cell International keeps more of each dollar of sales as profit, with a net margin of −6.2% compared with −246% at Celularity.
Celularity scores higher on the StockData Score (7 against 2 for Cryo-Cell International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CCEL | CELU |
|---|---|---|
| Size and price | ||
| Market cap | $39.1M | $20.4M |
| Share price | $4.85 | $0.630 |
| Change, 1 year | 19.8% | −62.5% |
| Change, 5 years | −60.4% | −99.1% |
| Beta (5Y) | 0.26 | 1.93 |
| Employees | 72 | 115 |
| StockData Score | ||
| Total score | 2 | 7 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.3× | 1.1× (better) |
| EV/EBITDA | 41.0× | – |
| P/FCF | 8.4× | – |
| FCF yield | 11.9% | – |
| Growth | ||
| Revenue growth (TTM) | −2.0% (better) | −58.1% |
| Revenue growth, 5Y average | 0.27% | 13.2% (better) |
| Profitability | ||
| Gross margin | 78.5% (better) | 19.2% |
| Operating margin | 0.61% (better) | −264% |
| Net margin | −6.2% (better) | −246% |
| FCF margin | 14.9% | – |
| Financial health | ||
| Net debt / EBITDA | 3.65 | – |
| Interest coverage | 0.1× | – |
| Current ratio | 0.86 (better) | 0.11 |
| Altman Z-score | −0.06 (better) | −16.48 |
| Piotroski F-score | 5 (better) | 1 |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 6.9% | 6.8% |
| Held by insiders | 41.7% | – |
| Short interest, % of float | 0.26% | – |
Go deeper
- CCEL stock overview
- CCEL income statement
- CCEL valuation and score
- CELU stock overview
- CELU income statement
- CELU valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.